Higher serum level of insulin-like growth factor I (IGF-I) has been associated with an increased risk of cancer by stimulating proliferation and suppressing apoptosis (Giovannucci et al., 2000; Liu et al., 2003). This evidence concerns the gene IGF1 and cancer.